{"gene":"HOXC8","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2004,"finding":"Menin associates with a trithorax-family histone methyltransferase complex containing MLL2 and Ash2L that methylates histone H3 on lysine 4; menin is bound to the Hoxc8 locus by chromatin immunoprecipitation, and Men1 knockout cells show decreased Hoxc8 expression.","method":"Co-immunoprecipitation, histone methyltransferase activity assay, chromatin immunoprecipitation (ChIP), Men1 knockout mouse/cell analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, in vitro HMT assay, ChIP at the Hoxc8 locus, and genetic KO with defined molecular phenotype in one study","pmids":["14992727"],"is_preprint":false},{"year":2000,"finding":"Smad1 physically interacts with Hoxc8 through two regions within its amino-terminal 87 amino acids; one of these regions binds the Hoxc8 homeodomain. Overexpression of these Smad1 interaction domains activates osteopontin transcription and induces osteoblast differentiation and mineralized bone matrix formation in 2T3 cells.","method":"Yeast two-hybrid, gel-shift (EMSA), deletion analysis, transient and stable transfection assays, alkaline phosphatase/mineralization readouts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding mapped by deletion mutagenesis, yeast two-hybrid confirmed by EMSA, functional rescue by domain overexpression with differentiation readout","pmids":["10625647"],"is_preprint":false},{"year":1993,"finding":"Hoxc8 protein binds DNA sequences in native chromatin and regulates expression of target genes including the mouse homologue of the Drosophila tumour-suppressor gene l(2)gl, identified by immunopurification of chromatin-bound DNA.","method":"Immunopurification of DNA bound to Hoxc8 in native chromatin (chromatin-IP precursor approach)","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromatin-binding experiment in vivo, single lab, single method","pmids":["8103190"],"is_preprint":false},{"year":1998,"finding":"Overexpression of a Hoxc8 transgene in mice causes cartilage defects characterized by accumulation of proliferating chondrocytes and reduced maturation, demonstrating that Hoxc8 controls the progression of cells along the chondrocyte differentiation pathway in a dosage-dependent and Hox-class-specific manner.","method":"Transgenic mouse overexpression with skeletal histological and cartilage-maturation phenotypic analysis; comparison with Hoxd4 and Isl-1 transgenics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic loss/gain-of-function with defined cellular phenotype, replicated across dosage levels, specificity demonstrated by comparison with other transgenes","pmids":["9707582"],"is_preprint":false},{"year":2005,"finding":"Hoxc8 directly binds the osteopontin (OPN/Spp1) promoter in vivo (confirmed by ChIP), repressing its expression ~4.8-fold; Hoxc8 also directly binds regulatory regions of five other genes (including Fzd2) involved in oncogenesis, cell adhesion, proliferation, and apoptosis.","method":"Mouse oligonucleotide microarray (16,463 genes), chromatin immunoprecipitation (ChIP) of endogenous Hoxc8 at target gene promoters","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP confirming direct promoter binding combined with expression profiling, multiple target genes validated","pmids":["15699330"],"is_preprint":false},{"year":1995,"finding":"A 135 bp early neural tube (ENT) enhancer located ~3 kb upstream of Hoxc8 directs posterior neural tube expression via four interdependent combinatorial elements (A–D); element A is essential but requires interaction with at least two of B, C, or D for activity.","method":"Deletion analysis and nucleotide substitution mutagenesis in transgenic mouse reporter assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis of cis-regulatory elements in transgenic mice with defined reporter readout, multiple combinatorial mutations tested","pmids":["8575334"],"is_preprint":false},{"year":1996,"finding":"A fifth cis-acting element (E) in the Hoxc8 early enhancer directs mesoderm expression in combination with elements A–D; different element combinations determine tissue-specific expression (neural tube: ABC/ABD/ACD; somite: ACDE; lateral plate mesoderm: DE), and mutations cause posteriorization of reporter expression.","method":"Transgenic mouse reporter assay with systematic cis-element mutation combinations","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic combinatorial mutagenesis in transgenic mice, multiple tissue-specific readouts, replicated across element combinations","pmids":["8901587"],"is_preprint":false},{"year":1996,"finding":"Regulatory elements that maintain the anterior boundaries of Hoxc8 expression in neural tube and paraxial mesoderm at later developmental stages are located 11–19 kb downstream of the Hoxc8 gene, demonstrating that long-range cis-regulatory elements govern the late phase of Hoxc8 expression.","method":"Yeast homologous recombination (pClasper vector) to clone 27 kb genomic region; reporter transgene analysis in transgenic mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic reporter assay with large genomic fragment, single lab, single approach","pmids":["8637890"],"is_preprint":false},{"year":1998,"finding":"Differences in cis-regulatory sequences of the Hoxc8 early enhancer between chicken and mouse cause a temporal delay in Hoxc8 activation in chicken, restricting its paraxial mesoderm expression to a more posterior domain; transgenic mouse assays show the chicken enhancer directs more posterior reporter expression than the mouse enhancer.","method":"Comparative sequence analysis; transgenic mouse reporter assays with chicken and mouse Hoxc8 early enhancer constructs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic reporter comparison across species enhancers, single lab","pmids":["9482889"],"is_preprint":false},{"year":2006,"finding":"Chromatin immunoprecipitation combined with microarray and high-throughput ChIP identified five direct Hoxc8 target genes (including OPN and Fzd2) out of 34 responsive genes; all five contain Hoxc8 consensus binding sites and encode proteins involved in oncogenesis, cell adhesion, proliferation, and apoptosis.","method":"Microarray expression profiling, genome-wide Hoxc8 DNA-binding site analysis, high-throughput ChIP","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (microarray + ChIP) identifying direct binding targets in vivo, single lab","pmids":["16793922"],"is_preprint":false},{"year":2008,"finding":"Transcription factor Ap2delta associates with Ash2l and the MLL family histone methyltransferase ALR/MLL2 in a complex that trimethylates H3K4; Ap2delta is required for recruitment of this complex to the Hoxc8 locus, leading to H3K4me3 and Hoxc8 transcriptional activation.","method":"Yeast two-hybrid screen, co-immunoprecipitation, ChIP for Ash2l/Alr and H3K4me3 at Hoxc8 locus, dose-dependent transactivation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid confirmed by endogenous Co-IP, ChIP at specific locus, functional transactivation assay, multiple orthogonal methods","pmids":["18495928"],"is_preprint":false},{"year":2010,"finding":"Lsh controls CpG methylation at the Hoxc8 locus; in wild-type cells, DNA methylation at Hoxc8 is associated with RNA Pol II stalling (not failure to bind) as the silencing mechanism. In Lsh-/- cells, hypomethylation at Hoxc8 permits efficient Pol II transcriptional elongation facilitated by the chromodomain protein Chd1.","method":"Lsh knockout mouse cells, DNA methylation analysis, Pol II ChIP, nucleosomal mapping, Chd1 functional assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple molecular readouts (methylation, Pol II ChIP, splicing), dynamic methylation manipulation experiments","pmids":["20161795"],"is_preprint":false},{"year":2010,"finding":"HOXC8 inhibits androgen receptor (AR)-mediated transcriptional induction in prostate cancer cells by blocking hormone-dependent recruitment of the coactivator SRC-3 and CBP to androgen-regulated gene enhancers, inhibiting histone acetylation; forced SRC-3 expression reverses HOXC8-mediated inhibition, and co-immunoprecipitation shows HOXC8 disrupts the AR–SRC-3 interaction.","method":"Transient transfection, ChIP for SRC-3/CBP/histone acetylation at PSA enhancer, co-immunoprecipitation, SRC-3 rescue experiment","journal":"Molecular cancer research : MCR","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP at specific androgen-regulated loci, Co-IP for AR–SRC-3 interaction, genetic rescue by SRC-3 overexpression, multiple orthogonal methods","pmids":["21047772"],"is_preprint":false},{"year":2006,"finding":"Immunoprecipitation of Pbx1 in prostate cancer DU145 cells reveals a Pbx1–HoxC8 heterocomplex; siRNA knockdown of either Pbx1 or HoxC8 suppresses androgen-independent cell growth, and double knockdown suppresses growth more significantly, indicating functional cooperation.","method":"Co-immunoprecipitation, siRNA knockdown, cell proliferation assay, DNA microarray","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP for complex, siRNA knockdown with proliferation readout, two orthogonal methods, single lab","pmids":["16637071"],"is_preprint":false},{"year":2011,"finding":"HOXC8 is required for cadherin 11 (CDH11) expression in breast cancer cells; HOXC8 depletion reduces CDH11 levels, actin-based membrane ruffles, and Rac activity; CDH11 interacts physically with Trio (a Rac GEF) and is required for Trio plasma membrane localization and Rac activation, placing HOXC8 upstream of a CDH11–Trio–Rac signaling axis in cell migration.","method":"siRNA knockdown, ectopic expression, co-immunoprecipitation (CDH11–Trio), Rac activity assay, active-Rac1 rescue, confocal imaging of membrane ruffles and Trio localization","journal":"Genes & cancer","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis established by rescue experiments, Co-IP for CDH11–Trio interaction, Rac activity assay, multiple orthogonal methods","pmids":["22593800"],"is_preprint":false},{"year":2014,"finding":"HOXC8 directly binds the CDH11 promoter at nucleotides -196 to -191 and acts as a transcriptional activator; depletion of HOXC8 reduces anchorage-independent growth, migration/invasion, and metastasis, all of which are rescued by ectopic CDH11 expression.","method":"Chromatin immunoprecipitation, luciferase promoter assay, siRNA knockdown, ectopic CDH11 rescue, soft-agar and invasion assays","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP confirming direct promoter binding, site-specific luciferase assay, genetic rescue establishing epistasis, multiple functional readouts","pmids":["24810778"],"is_preprint":false},{"year":2015,"finding":"HOXC8 directly binds the embigin (EMB) promoter at nucleotides -2303 to -2315 and acts as a transcriptional repressor; HOXC8 knockdown increases EMB expression, and the pro-tumorigenic effects of HOXC8 knockdown (increased proliferation, migration) are rescued by co-depletion of embigin.","method":"Western blot, luciferase reporter gene assay, chromatin immunoprecipitation, siRNA knockdown, epistasis rescue experiments","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP at specific promoter site, luciferase assay, genetic rescue establishing epistasis, single lab with multiple orthogonal methods","pmids":["26090721"],"is_preprint":false},{"year":2007,"finding":"Endogenous Hoxc8 binds directly to the enhancer region of mouse naked cuticle 2 (mNkd2) gene; introduction of exogenous Hoxc8 into NIH3T3 cells reduces mNkd2 mRNA expression, establishing mNkd2 as a direct transcriptional target through which Hoxc8 cross-talks with the Wnt signaling pathway.","method":"Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), reporter assay, mRNA expression analysis after Hoxc8 overexpression","journal":"Journal of experimental zoology. Part A, Ecological genetics and physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — three orthogonal methods (ChIP, EMSA, reporter assay) in single lab establishing direct binding and transcriptional repression","pmids":["17094106"],"is_preprint":false},{"year":2009,"finding":"Hoxc8 overexpression suppresses basal Smad6 promoter activity and BMP2/Smad1-induced Smad6 transcription; ChIP from mouse embryos shows both Smad1 and Hoxc8 are present at the Smad6 promoter, suggesting Hoxc8 regulates Smad6 indirectly through a complex with Smad1 (no direct Hox binding motif in the Smad6 promoter).","method":"Promoter luciferase assay, RT-PCR, chromatin immunoprecipitation with anti-Smad1 and anti-Hoxc8 antibodies in mouse embryos","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP in embryos + promoter assay, but indirect mechanism proposed since no Hox binding motif in promoter; single lab","pmids":["20016939"],"is_preprint":false},{"year":2010,"finding":"Proliferating cell nuclear antigen (Pcna) is a direct transcriptional target of Hoxc8; Hoxc8 binds Hox core and Hox-Pbx binding sequences in the Pcna upstream regulatory region (confirmed by ChIP in embryos), overexpression of Hoxc8 increases Pcna transcript levels and cell proliferation rate.","method":"Chromatin immunoprecipitation in mouse embryos (E11.5), promoter sequence analysis, Hoxc8 overexpression with RT-PCR and proliferation assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP in vivo confirming direct binding, functional overexpression assay; single lab, two methods","pmids":["20097160"],"is_preprint":false},{"year":2005,"finding":"Retinaldehyde dehydrogenase 2 (Raldh2) conditional knockout causes loss of Lim1+ brachial motoneurons and Islet1+ neuron mispositioning; the molecular basis involves deregulation of Hoxc8, which regulates RARbeta. Hoxc8 mutant mice exhibit the same motoneuron specification defects (phenocopy), establishing Hoxc8 downstream of Raldh2/RA signaling in brachial motoneuron specification.","method":"Conditional knockout (Raldh2 and Hoxc8 null mice), immunofluorescence for motoneuron markers (Lim1, Islet1), molecular phenotype comparison","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis by two independent mouse KO models with defined molecular and cellular phenotypes","pmids":["15753214"],"is_preprint":false},{"year":2015,"finding":"LMP1 (EBV) represses HoxC8 expression in nasopharyngeal carcinoma cells via RNA Pol II stalling, partially reversible by irradiation through epigenetic regulator TET3; HoxC8 modulates glycolysis and regulates TCA cycle-related gene expression, and ectopic HoxC8 inhibits NPC cell growth in vitro and in vivo.","method":"RNA Pol II ChIP, TET3 manipulation, ectopic HoxC8 expression, glycolysis assays, in vivo xenograft","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Pol II ChIP mechanistic data, functional ectopic expression with metabolic and in vivo readouts; single lab","pmids":["25745994"],"is_preprint":false},{"year":2018,"finding":"HOXC8 functions as a transcriptional activator of TGFβ1, and this elevated TGFβ1 mediates HOXC8-driven proliferation, anchorage-independent growth, migration, and chemoresistance in non-small cell lung cancer cells.","method":"ChIP, promoter luciferase assay, siRNA knockdown, ectopic overexpression, TGFβ1 blocking rescue experiments, colony formation and migration assays","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase assay for direct TGFβ1 transcriptional activation, functional rescue experiments; single lab","pmids":["29367650"],"is_preprint":false},{"year":2017,"finding":"ILF3 physically interacts with HOXC8 (co-immunoprecipitation and mass spectrometry) and they cooperate to activate CDH11 transcription; ILF3 binds CDH11 promoter at specific nucleotide positions and requires HOXC8 for co-activation.","method":"Co-immunoprecipitation, mass spectrometry, ChIP, luciferase reporter assay, siRNA knockdown","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP + MS for interaction, ChIP for binding, luciferase for co-activation; single lab with multiple orthogonal methods","pmids":["29296180"],"is_preprint":false},{"year":2019,"finding":"HOXC8 directly activates transcription of MGP (matrix Gla protein) by binding its promoter; elevated MGP promotes EMT and drives proliferation and migration specifically in triple-negative breast cancer cells.","method":"Chromatin immunoprecipitation, luciferase assay, siRNA knockdown and overexpression, EMT marker analysis","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus luciferase confirming direct binding and transcriptional activation, functional knockdown/OE; single lab","pmids":["31264274"],"is_preprint":false},{"year":2022,"finding":"Sustained Hoxc8 activity is required not only to establish but also to maintain terminal differentiation markers in brachial spinal motor neurons postnatally; conditional inactivation of Hoxc8 at successive developmental stages causes motor deficits, and in vitro-generated MNs show Hoxc8 is sufficient to induce terminal differentiation gene expression directly.","method":"Conditional Hoxc8 knockout in mice at successive stages, transcriptomics of brachial MNs, motor behavioral assays, in vitro MN generation with Hoxc8 gain/loss-of-function","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO at multiple stages with defined behavioral and molecular phenotypes, in vitro gain-of-function, transcriptomic validation","pmids":["35315772"],"is_preprint":false},{"year":2012,"finding":"Cdx1 directly binds three pairs of conserved Cdx binding sites in the HoxC8 early enhancer during Xenopus embryogenesis (confirmed by ChIP); Cdx1 overexpression or knockdown causes precocious or delayed HoxC8 expression respectively, establishing Cdx1 as a direct transcriptional activator of HoxC8 expression.","method":"Xenopus Cdx1 overexpression and antisense morpholino knockdown, transgenic reporter (mouse HoxC8 early enhancer in Xenopus), ChIP for Cdx1 binding in embryos, Cdx binding site mutagenesis","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP in embryos confirming direct binding, gain- and loss-of-function genetic experiments, mutagenesis of binding sites; multiple orthogonal methods","pmids":["22426122"],"is_preprint":false},{"year":2017,"finding":"Gdf11/Smad signaling and Cdx proteins synergistically activate the Hoxc8 early enhancer; mutagenesis identified two Smad binding motifs and two Cdx binding motifs as required elements; Gdf11 stimulation is partially inhibited by Specific Inhibitor of Smad3, implicating Smad3 in signal transduction.","method":"Luciferase reporter transfection in HepG2 cells, Gdf11/Cdx overexpression, site-directed mutagenesis of enhancer motifs, Smad3 inhibitor","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis of specific binding sites in reporter assay, pharmacological inhibition; single lab, cell-line model","pmids":["28695962"],"is_preprint":false},{"year":2008,"finding":"The 16 amino acid third helix (residues 191–206) of the Hoxc8 homeodomain is a protein transduction domain (PTD) sufficient for cellular membrane penetration; transduction efficiency increases with PTD copy number. The homeodomain region of Hoxc8 is also required for forming protein–DNA complexes that can be delivered intracellularly.","method":"GFP-fusion protein transduction assay in primary pig fibroblasts and COS-7 cells, gel retardation/agarose gel DNA-complex assay, concentration-response and multimer experiments","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct transduction assay with peptide domain, replicated in multiple cell types, dose-response characterized; single lab","pmids":["18835255"],"is_preprint":false},{"year":2023,"finding":"HOXC8 activates TGFβ1 transcription and enhances phosphorylated Smad2/Smad3 levels in hepatic stellate cells, creating a positive feedback loop; knockdown of HOXC8 suppresses TGF-β1-induced HSC activation and fibrotic gene (α-SMA, COL1a1) induction in vitro and alleviates liver fibrosis in a CCl4 mouse model in vivo.","method":"HOXC8 overexpression and knockdown in LX-2 cells and CCl4 mouse model, Western blot for phospho-Smad2/3, qPCR for fibrotic genes, luciferase/ChIP implied by context of TGFβ1 activation claim","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO phenotype plus in vitro mechanistic signaling data; positive feedback loop inferred from expression data; single lab","pmids":["37099809"],"is_preprint":false},{"year":2025,"finding":"HOXC8 negatively regulates CASP1 (caspase-1) expression by recruiting HDAC1/2 to the CASP1 promoter; HOXC8 and HDAC1 are in the same immunocomplex and HOXC8 is required for HDAC1 recruitment to the CASP1 promoter, suppressing CASP1 transcription and thereby preventing pyroptosis in NSCLC cells.","method":"Co-immunoprecipitation (HOXC8–HDAC1), ChIP (HOXC8 and HDAC1 at CASP1 promoter), siRNA knockdown, YVAD/disulfiram rescue of pyroptosis, CASP1 forced expression, cholesterol-conjugated siRNA in vivo","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP for complex, ChIP for direct promoter binding and HDAC1 recruitment, pharmacological and genetic rescue establishing mechanism, in vivo validation; multiple orthogonal methods","pmids":["40701951"],"is_preprint":false},{"year":2025,"finding":"Hoxc8 is a central pro-fibrotic transcription factor downstream of TGF-β–Smad3 signaling in kidney fibrosis; Hoxc8 reinforces its own expression and drives fibrotic gene programs by recruiting the P-TEFb transcriptional elongation complex; fibroblast-specific Hoxc8 deletion protects mice from renal fibrosis.","method":"Transcriptomic and cistromic (ChIP-seq implied) analyses, fibroblast-specific conditional Hoxc8 knockout mice, methionine restriction dietary model, histone mark analysis at Hoxc8 locus","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined fibrosis phenotype, cistromic identification of P-TEFb recruitment, epigenomic analysis; multiple orthogonal approaches in single study","pmids":["41476080"],"is_preprint":false},{"year":2010,"finding":"miR-196a/b directly targets the HOXC8 3'UTR (confirmed by luciferase reporter), suppressing HOXC8 protein expression; HOXC8 knockdown suppresses breast cancer cell migration and metastasis, and ectopic HOXC8 expression rescues the anti-migratory effect of miR-196, placing HOXC8 downstream of miR-196 in a migration-regulatory axis.","method":"Luciferase 3'UTR reporter assay, siRNA knockdown, lentiviral miRNA overexpression, in vitro invasion, in vivo spontaneous metastasis assay, HOXC8 ectopic rescue","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct 3'UTR validation, genetic epistasis by rescue, both in vitro and in vivo functional readouts","pmids":["20736365"],"is_preprint":false},{"year":2011,"finding":"miR-196a directly interacts with the HOX-C8 3'UTR (confirmed by luciferase assay with different HOX-C8 3'UTR fragments), and stable miR-196a expression down-regulates HOX-C8 in melanoma cells, leading to changes in HOX-C8 target genes cadherin-11, calponin-1, and osteopontin.","method":"Luciferase 3'UTR reporter assay with deletion fragments, stable miR-196a transfection, target gene expression analysis","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3'UTR luciferase validation, gene expression downstream effects; single lab","pmids":["21077158"],"is_preprint":false},{"year":2020,"finding":"DLX5 and HOXC8 form a protein complex and together bind and negatively regulate the LINC01013 lncRNA promoter; co-expression of DLX5 and HOXC8 enhances chondrogenic differentiation of stem cells from apical papilla (SCAPs) in vitro and restores cartilage defect in a rabbit knee model in vivo.","method":"Co-immunoprecipitation (DLX5–HOXC8 complex), ChIP at LINC01013 promoter, Western blot, Alcian Blue staining, pellet culture, in vivo rabbit cartilage transplantation","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for complex, ChIP at promoter, in vivo functional assay; single lab with multiple methods","pmids":["32631410"],"is_preprint":false},{"year":2025,"finding":"HOXC8 in cancer-associated fibroblasts (CAFs) directly binds the GCH1 promoter and activates its transcription (confirmed by dual luciferase reporter and bioinformatics); HOXC8-driven GCH1 upregulation suppresses ferroptosis and promotes lung cancer cell malignant progression; si-HOXC8 in CAFs inhibited tumor growth and GCH1 expression in vivo.","method":"Dual luciferase reporter assay, bioinformatics binding analysis, siRNA knockdown, GCH1 overexpression rescue, xenograft tumor model, IHC","journal":"Pathology, research and practice","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay confirming direct promoter binding, genetic rescue establishing epistasis, in vivo validation; single lab","pmids":["41505981"],"is_preprint":false},{"year":2025,"finding":"HOXC8 transcriptionally activates TRIM22 expression, leading to ubiquitination and degradation of IκBα and subsequent NF-κB signaling activation; this HOXC8/TRIM22/NF-κB axis drives stemness and chemoresistance in colorectal cancer cells.","method":"ChIP for HOXC8 at TRIM22 promoter, IκBα ubiquitination assay, NF-κB pathway reporter, siRNA knockdown and overexpression, stemness/sphere-formation assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct TRIM22 promoter binding, ubiquitination assay, pathway rescue; single lab","pmids":["41265630"],"is_preprint":false},{"year":2020,"finding":"HOXC8 overexpression in endometrial stromal cells significantly enhances cell proliferation, migration, adhesion, and fibrotic activities, and increases phosphorylated SMAD2/SMAD3 levels; the adhesion and fibrosis activities induced by HOXC8 are blocked by TGF-β receptor type I kinase inhibitor E-616452, placing HOXC8 upstream of TGF-β/SMAD signaling.","method":"HOXC8 overexpression in euESCs, cell function assays (proliferation, migration, adhesion, fibrosis), Western blot for phospho-SMAD2/3, pharmacological TGFβRI inhibition","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with multiple functional readouts and pharmacological pathway inhibition; single lab","pmids":["32877504"],"is_preprint":false},{"year":2008,"finding":"Morpholino-mediated knockdown of Hoxc8 in primary chondrocytes reduces cell proliferation (decreased PCNA expression and phospho-histone H3) without apoptosis, and causes cells to be delayed in M-phase progression, implicating Hoxc8 in cell cycle control at the M-phase checkpoint.","method":"Morpholino antisense knockdown in primary chondrocytes, PCNA immunostaining, phospho-Histone H3 staining, BrdU incorporation, flow cytometry","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct knockdown in primary cells with cell-cycle marker readouts; single lab, single method","pmids":["19071237"],"is_preprint":false}],"current_model":"HOXC8 is a homeodomain transcription factor that directly binds DNA at target gene promoters/enhancers to activate or repress transcription; it interacts physically with Smad1/BMP-pathway components, the Pbx1 co-factor, SRC-3 coactivator, ILF3, DLX5, HDAC1, and P-TEFb; its locus is epigenetically regulated by menin/MLL2-Ash2L H3K4 methyltransferase complex (recruited by Ap2delta), by Lsh-dependent DNA methylation causing Pol II stalling, and by KDM5A-mediated H3K4 demethylation; upstream, it is activated by Cdx1 binding to its early enhancer and by TGF-β/Smad3 signaling, and post-transcriptionally repressed by miR-196 family members targeting its 3'UTR; functionally, HOXC8 controls chondrocyte proliferation and differentiation, brachial motoneuron specification and terminal differentiation, osteoblast differentiation (as a negative regulator), and in cancer contexts drives migration/invasion via a CDH11–Trio–Rac axis, suppresses pyroptosis by recruiting HDAC1/2 to repress CASP1 transcription, and promotes fibrosis through TGFβ1 positive feedback and P-TEFb recruitment."},"narrative":{"mechanistic_narrative":"HOXC8 is a homeodomain transcription factor that directs anteroposterior patterning of the developing skeleton and nervous system and is repeatedly redeployed as a driver of cancer and fibrosis [PMID:8103190, PMID:9707582, PMID:15753214]. It binds DNA at Hox core and Hox-Pbx consensus sites in native chromatin to either activate or repress target promoters, regulating genes governing cell adhesion, proliferation, oncogenesis, and apoptosis [PMID:8103190, PMID:15699330, PMID:16793922, PMID:20097160]. In development, HOXC8 controls progression of chondrocytes through differentiation in a dosage-dependent manner [PMID:9707582, PMID:19071237] and acts downstream of retinaldehyde/RA signaling to specify and maintain terminal differentiation of brachial spinal motor neurons, with sustained activity required postnatally [PMID:15753214, PMID:35315772]. Its developmental expression is established and bounded by a modular early enhancer whose combinatorial cis-elements direct distinct neural tube, somite, and lateral plate mesoderm domains [PMID:8575334, PMID:8901587, PMID:8637890]; this enhancer integrates Cdx1 and Gdf11/Smad3 inputs that time and position HOXC8 activation [PMID:22426122, PMID:28695962]. HOXC8 partners directly with Smad1 through its homeodomain to control BMP-responsive osteogenic transcription [PMID:10625647], and forms complexes with Pbx1, ILF3, DLX5, and HDAC1/2 to specify target selection and activity [PMID:16637071, PMID:29296180, PMID:32631410, PMID:40701951]. In cancer, HOXC8 activates CDH11 to engage a CDH11–Trio–Rac migration axis and drive invasion and metastasis [PMID:22593800, PMID:24810778], suppresses pyroptosis by recruiting HDAC1/2 to repress CASP1 [PMID:40701951], and acts upstream of TGFβ1/Smad signaling; in hepatic stellate cells and renal fibroblasts it establishes a TGFβ1–Smad positive-feedback loop and recruits the P-TEFb elongation complex to drive fibrotic gene programs [PMID:29367650, PMID:37099809, PMID:41476080, PMID:32877504]. The HOXC8 locus is itself a node of epigenetic control, activated by Ap2δ-recruited menin/MLL2-Ash2L H3K4 methyltransferase activity and silenced by Lsh-dependent DNA methylation that stalls RNA Pol II [PMID:14992727, PMID:18495928, PMID:20161795]; post-transcriptionally, miR-196 family members target its 3'UTR to limit HOXC8 protein and its migratory output [PMID:20736365, PMID:21077158].","teleology":[{"year":1993,"claim":"Established that Hoxc8 protein occupies specific DNA sequences in living chromatin and regulates downstream target genes, defining it as a sequence-specific transcriptional regulator rather than merely a patterning marker.","evidence":"Immunopurification of Hoxc8-bound DNA from native chromatin in mouse","pmids":["8103190"],"confidence":"Medium","gaps":["Direct binding motif not yet defined","Activation versus repression at targets not resolved","Single method, single lab"]},{"year":1996,"claim":"Resolved how spatial and temporal HOXC8 expression is encoded, showing combinatorial cis-regulatory elements in an early enhancer plus long-range downstream elements partition expression into tissue-specific domains.","evidence":"Systematic cis-element mutagenesis in transgenic mouse reporters and large genomic fragment analysis","pmids":["8575334","8901587","8637890"],"confidence":"High","gaps":["Trans-acting factors binding each element not identified at this stage","Mechanism of element interdependence unknown"]},{"year":1998,"claim":"Demonstrated that HOXC8 dosage controls chondrocyte differentiation progression, linking the patterning factor to a concrete cellular differentiation phenotype.","evidence":"Transgenic mouse overexpression with cartilage histology, compared against other Hox transgenes","pmids":["9707582"],"confidence":"High","gaps":["Direct chondrocyte target genes not identified","Molecular mechanism of maturation arrest unresolved"]},{"year":2000,"claim":"Identified a direct physical link between HOXC8 and BMP signaling, showing Smad1 binds the homeodomain to control osteogenic transcription and bone matrix formation.","evidence":"Yeast two-hybrid, EMSA, deletion mapping, and differentiation/mineralization assays in 2T3 cells","pmids":["10625647"],"confidence":"High","gaps":["Genome-wide Smad1–Hoxc8 co-targets not mapped","Whether interaction is activating or repressive context-dependent"]},{"year":2006,"claim":"Provided genome-scale direct target identification, defining a HOXC8 consensus and a cohort of bound, regulated genes (e.g., OPN, Fzd2) implicated in adhesion, proliferation, and apoptosis.","evidence":"Expression microarray combined with high-throughput ChIP for endogenous Hoxc8","pmids":["15699330","16793922"],"confidence":"High","gaps":["Cell-type dependence of target repertoire not addressed","Co-factor requirements at each site not defined"]},{"year":2006,"claim":"Showed HOXC8 cooperates with the Pbx1 co-factor in a heterocomplex to sustain androgen-independent prostate cancer growth, framing HOXC8 as a context-dependent oncogenic regulator.","evidence":"Co-IP and siRNA double knockdown with proliferation readouts in DU145 cells","pmids":["16637071"],"confidence":"Medium","gaps":["Direct co-bound target genes not identified","Two methods, single lab"]},{"year":2008,"claim":"Defined epigenetic activation of the Hoxc8 locus by H3K4 methyltransferase complexes, showing Ap2δ recruits Ash2l/MLL2 to deposit H3K4me3 and drive transcription, building on the earlier menin–MLL2 link.","evidence":"Yeast two-hybrid, Co-IP, locus ChIP for Ash2l/Alr and H3K4me3, transactivation assay","pmids":["18495928","14992727"],"confidence":"High","gaps":["Signals controlling Ap2δ recruitment unknown","Relationship to repressive marks not integrated"]},{"year":2010,"claim":"Revealed a silencing mechanism in which Lsh-dependent CpG methylation at the locus stalls RNA Pol II elongation rather than blocking recruitment, identifying elongation control as a key regulatory layer.","evidence":"Lsh knockout cells with methylation analysis, Pol II ChIP, nucleosome mapping, and Chd1 assays","pmids":["20161795"],"confidence":"High","gaps":["Trigger for Lsh-mediated methylation not defined","Interplay with activating H3K4 machinery unresolved"]},{"year":2010,"claim":"Established post-transcriptional control of HOXC8 by miR-196 family targeting of its 3'UTR, placing HOXC8 downstream of a microRNA axis governing cancer cell migration and metastasis.","evidence":"3'UTR luciferase reporters, miRNA overexpression, in vitro/in vivo metastasis with HOXC8 rescue","pmids":["20736365","21077158"],"confidence":"High","gaps":["Relative contribution of individual miR-196 family members unclear","Upstream regulation of miR-196 not addressed"]},{"year":2010,"claim":"Showed HOXC8 antagonizes nuclear receptor coactivation, blocking AR-dependent SRC-3/CBP recruitment and histone acetylation, demonstrating it can act by sequestering coactivators.","evidence":"ChIP at the PSA enhancer, Co-IP, and SRC-3 overexpression rescue in prostate cancer cells","pmids":["21047772"],"confidence":"High","gaps":["Generality across other nuclear receptors not tested","Structural basis of AR–SRC-3 disruption unknown"]},{"year":2011,"claim":"Connected HOXC8 to a defined cytoskeletal signaling axis, showing it drives CDH11 expression to enable Trio-dependent Rac activation and membrane ruffling in migrating breast cancer cells.","evidence":"siRNA, Co-IP (CDH11–Trio), Rac activity assays, active-Rac1 rescue, and imaging","pmids":["22593800"],"confidence":"High","gaps":["Whether HOXC8 binds CDH11 directly resolved only later","In vivo relevance of the Trio–Rac axis not tested here"]},{"year":2014,"claim":"Confirmed direct, site-specific HOXC8 activation of the CDH11 promoter and established epistasis, with CDH11 re-expression rescuing migration, invasion, and metastasis defects.","evidence":"ChIP, site-mapped luciferase assays, siRNA, CDH11 rescue, soft-agar and invasion assays","pmids":["24810778"],"confidence":"High","gaps":["Co-factors at the CDH11 promoter defined only in later work","Determinants of activation versus repression at different targets unclear"]},{"year":2018,"claim":"Identified TGFβ1 as a direct HOXC8 transcriptional target mediating proliferation, anchorage independence, migration, and chemoresistance, linking HOXC8 to TGFβ-driven malignancy.","evidence":"ChIP, luciferase, knockdown/overexpression, and TGFβ1-blocking rescue in NSCLC cells","pmids":["29367650"],"confidence":"Medium","gaps":["Feedback architecture established only in later fibrosis studies","Single lung cancer context"]},{"year":2022,"claim":"Demonstrated that HOXC8 is required continuously, not just transiently, to maintain motor neuron terminal differentiation, redefining it as a sustained identity factor rather than an initiation-only switch.","evidence":"Stage-specific conditional Hoxc8 knockout, brachial MN transcriptomics, behavior, and in vitro gain-of-function","pmids":["35315772"],"confidence":"High","gaps":["Direct terminal differentiation target genes not exhaustively mapped","Maintenance co-factors not identified"]},{"year":2025,"claim":"Mechanistically unified HOXC8 as a pro-fibrotic master regulator that establishes a TGFβ1–Smad self-reinforcing loop and recruits the P-TEFb elongation complex to drive fibrotic transcription in liver and kidney.","evidence":"Conditional/fibroblast-specific knockouts, CCl4 and renal fibrosis models, phospho-Smad and cistromic/histone analyses","pmids":["37099809","41476080","32877504"],"confidence":"High","gaps":["Direct mechanism of P-TEFb recruitment to the HOXC8 cistrome not structurally defined","How fibrotic and developmental target programs are partitioned unknown"]},{"year":2025,"claim":"Extended HOXC8 repressive output to programmed cell death, showing it recruits HDAC1/2 to silence CASP1 and suppress pyroptosis, demonstrating a chromatin-modifier-based repression mechanism.","evidence":"Co-IP (HOXC8–HDAC1), ChIP for HOXC8/HDAC1 at the CASP1 promoter, rescue experiments, and in vivo siRNA in NSCLC","pmids":["40701951"],"confidence":"High","gaps":["Determinants directing HDAC recruitment to specific promoters unknown","Generality of pyroptosis suppression beyond NSCLC untested"]},{"year":null,"claim":"It remains unresolved what molecular logic dictates whether HOXC8 activates or represses a given target and how its developmental versus pro-fibrotic/oncogenic cistromes are selected across cell types.","evidence":"No single study in the corpus integrates the co-factor/chromatin determinants of HOXC8 target choice across contexts","pmids":[],"confidence":"Low","gaps":["No unified model of activator-versus-repressor switching","Cell-type-specific cistrome determinants not defined","Structural basis of partner-directed target selection unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,4,9,15,16,17,22,24,30,31]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,4,15,16,17,28]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[12,18,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4,9,30]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,9,15,16,30,31]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,5,6,20,25]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,10,11,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,14,22,29,36]}],"complexes":["P-TEFb (recruited)"],"partners":["SMAD1","PBX1","ILF3","DLX5","HDAC1","NCOA3","TRIO"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P31273","full_name":"Homeobox protein Hox-C8","aliases":["Homeobox protein Hox-3A"],"length_aa":242,"mass_kda":27.8,"function":"Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P31273/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HOXC8","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HOXC8","total_profiled":1310},"omim":[{"mim_id":"612758","title":"TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1","url":"https://www.omim.org/entry/612758"},{"mim_id":"609688","title":"MICRO RNA 196B; MIR196B","url":"https://www.omim.org/entry/609688"},{"mim_id":"609687","title":"MICRO RNA 196A2; MIR196A2","url":"https://www.omim.org/entry/609687"},{"mim_id":"608632","title":"MICRO RNA 196A1; MIR196A1","url":"https://www.omim.org/entry/608632"},{"mim_id":"608119","title":"HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR; HOMEZ","url":"https://www.omim.org/entry/608119"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Microtubules","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"epididymis","ntpm":14.6},{"tissue":"skeletal muscle","ntpm":14.6}],"url":"https://www.proteinatlas.org/search/HOXC8"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOX3","HOX3A"]},"alphafold":{"accession":"P31273","domains":[{"cath_id":"1.10.10.60","chopping":"157-210_228-242","consensus_level":"medium","plddt":89.9796,"start":157,"end":242}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31273","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31273-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31273-F1-predicted_aligned_error_v6.png","plddt_mean":64.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HOXC8","jax_strain_url":"https://www.jax.org/strain/search?query=HOXC8"},"sequence":{"accession":"P31273","fasta_url":"https://rest.uniprot.org/uniprotkb/P31273.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31273/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31273"}},"corpus_meta":[{"pmid":"14992727","id":"PMC_14992727","title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14992727","citation_count":525,"is_preprint":false},{"pmid":"20736365","id":"PMC_20736365","title":"Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20736365","citation_count":129,"is_preprint":false},{"pmid":"8103190","id":"PMC_8103190","title":"A mouse homologue of the Drosophila tumour-suppressor gene l(2)gl controlled by Hox-C8 in vivo.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8103190","citation_count":103,"is_preprint":false},{"pmid":"21077158","id":"PMC_21077158","title":"MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21077158","citation_count":101,"is_preprint":false},{"pmid":"11813208","id":"PMC_11813208","title":"Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation.","date":"2002","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/11813208","citation_count":98,"is_preprint":false},{"pmid":"10625647","id":"PMC_10625647","title":"Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10625647","citation_count":86,"is_preprint":false},{"pmid":"9482889","id":"PMC_9482889","title":"Modification of expression and cis-regulation of Hoxc8 in the evolution of diverged axial morphology.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9482889","citation_count":84,"is_preprint":false},{"pmid":"9707582","id":"PMC_9707582","title":"Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9707582","citation_count":82,"is_preprint":false},{"pmid":"15699330","id":"PMC_15699330","title":"The identification of Hoxc8 target genes.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15699330","citation_count":79,"is_preprint":false},{"pmid":"8575334","id":"PMC_8575334","title":"Regulation of Hoxc-8 during mouse embryonic development: identification and characterization of critical elements involved in early neural tube expression.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8575334","citation_count":78,"is_preprint":false},{"pmid":"29367650","id":"PMC_29367650","title":"HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer.","date":"2018","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29367650","citation_count":68,"is_preprint":false},{"pmid":"10208853","id":"PMC_10208853","title":"HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10208853","citation_count":67,"is_preprint":false},{"pmid":"15753214","id":"PMC_15753214","title":"Retinaldehyde dehydrogenase 2 and Hoxc8 are required in the murine brachial spinal cord for the specification of Lim1+ motoneurons and the correct distribution of Islet1+ motoneurons.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15753214","citation_count":64,"is_preprint":false},{"pmid":"25745994","id":"PMC_25745994","title":"Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25745994","citation_count":58,"is_preprint":false},{"pmid":"8901587","id":"PMC_8901587","title":"Combinations of closely situated cis-acting elements determine tissue-specific patterns and anterior extent of early Hoxc8 expression.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8901587","citation_count":51,"is_preprint":false},{"pmid":"8637890","id":"PMC_8637890","title":"A long-range regulatory element of Hoxc8 identified by using the pClasper vector.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8637890","citation_count":51,"is_preprint":false},{"pmid":"9860988","id":"PMC_9860988","title":"Comparative studies on mammalian Hoxc8 early enhancer sequence reveal a baleen whale-specific deletion of a cis-acting element.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9860988","citation_count":47,"is_preprint":false},{"pmid":"28202042","id":"PMC_28202042","title":"HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.","date":"2017","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28202042","citation_count":46,"is_preprint":false},{"pmid":"16637071","id":"PMC_16637071","title":"PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.","date":"2006","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/16637071","citation_count":46,"is_preprint":false},{"pmid":"21047772","id":"PMC_21047772","title":"HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.","date":"2010","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21047772","citation_count":44,"is_preprint":false},{"pmid":"31264274","id":"PMC_31264274","title":"Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.","date":"2019","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31264274","citation_count":43,"is_preprint":false},{"pmid":"33061608","id":"PMC_33061608","title":"Downregulation of circNRIP1 Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-211-5p/HOXC8 Axis.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33061608","citation_count":42,"is_preprint":false},{"pmid":"16793922","id":"PMC_16793922","title":"Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16793922","citation_count":41,"is_preprint":false},{"pmid":"22514613","id":"PMC_22514613","title":"The crest phenotype in chicken is associated with ectopic expression of HOXC8 in cranial skin.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22514613","citation_count":41,"is_preprint":false},{"pmid":"34017077","id":"PMC_34017077","title":"FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34017077","citation_count":40,"is_preprint":false},{"pmid":"9723177","id":"PMC_9723177","title":"Multiple phases of expression and regulation of mouse Hoxc8 during early embryogenesis.","date":"1998","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/9723177","citation_count":37,"is_preprint":false},{"pmid":"22593800","id":"PMC_22593800","title":"HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac.","date":"2011","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22593800","citation_count":36,"is_preprint":false},{"pmid":"32631410","id":"PMC_32631410","title":"DLX5 and HOXC8 enhance the chondrogenic differentiation potential of stem cells from apical papilla via LINC01013.","date":"2020","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32631410","citation_count":36,"is_preprint":false},{"pmid":"20161795","id":"PMC_20161795","title":"Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20161795","citation_count":36,"is_preprint":false},{"pmid":"24810778","id":"PMC_24810778","title":"HOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24810778","citation_count":33,"is_preprint":false},{"pmid":"24525058","id":"PMC_24525058","title":"The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.","date":"2014","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/24525058","citation_count":31,"is_preprint":false},{"pmid":"35315772","id":"PMC_35315772","title":"Control of spinal motor neuron terminal differentiation through sustained Hoxc8 gene activity.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35315772","citation_count":31,"is_preprint":false},{"pmid":"18495928","id":"PMC_18495928","title":"Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18495928","citation_count":31,"is_preprint":false},{"pmid":"21712827","id":"PMC_21712827","title":"Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma.","date":"2011","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21712827","citation_count":28,"is_preprint":false},{"pmid":"9919689","id":"PMC_9919689","title":"Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice.","date":"1999","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/9919689","citation_count":27,"is_preprint":false},{"pmid":"20126390","id":"PMC_20126390","title":"Expression of cartilage developmental genes in Hoxc8- and Hoxd4-transgenic mice.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20126390","citation_count":26,"is_preprint":false},{"pmid":"29296180","id":"PMC_29296180","title":"Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29296180","citation_count":25,"is_preprint":false},{"pmid":"38641828","id":"PMC_38641828","title":"N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.","date":"2024","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/38641828","citation_count":24,"is_preprint":false},{"pmid":"14673077","id":"PMC_14673077","title":"Divergence of Hoxc8 early enhancer parallels diverged axial morphologies between mammals and fishes.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14673077","citation_count":24,"is_preprint":false},{"pmid":"26459221","id":"PMC_26459221","title":"Hoxc8 initiates an ectopic mammary program by regulating Fgf10 and Tbx3 expression and Wnt/β-catenin signaling.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26459221","citation_count":21,"is_preprint":false},{"pmid":"20508826","id":"PMC_20508826","title":"Mouse Homologue of the Schizophrenia Susceptibility Gene ZNF804A as a Target of Hoxc8.","date":"2010","source":"Journal of biomedicine & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/20508826","citation_count":19,"is_preprint":false},{"pmid":"32158227","id":"PMC_32158227","title":"LncRNA SNHG1 Regulates the Progression of Esophageal Squamous Cell Cancer by the miR-204/HOXC8 Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32158227","citation_count":18,"is_preprint":false},{"pmid":"28093668","id":"PMC_28093668","title":"Molecular characterization of HOXC8 gene and methylation status analysis of its exon 1 associated with the length of cashmere fiber in Liaoning cashmere goat.","date":"2017","source":"Genetica","url":"https://pubmed.ncbi.nlm.nih.gov/28093668","citation_count":17,"is_preprint":false},{"pmid":"12713673","id":"PMC_12713673","title":"Normal proliferation and differentiation of Hoxc-8 transgenic chondrocytes in vitro.","date":"2003","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12713673","citation_count":17,"is_preprint":false},{"pmid":"32772270","id":"PMC_32772270","title":"MiR-148a-3p may contribute to flawed decidualization in recurrent implantation failure by modulating HOXC8.","date":"2020","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32772270","citation_count":16,"is_preprint":false},{"pmid":"27796868","id":"PMC_27796868","title":"Effect of rs11614913 Polymorphism on Mature miR196a2 Expression and its Target Gene HOXC8 Expression in Human Glioma.","date":"2016","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/27796868","citation_count":16,"is_preprint":false},{"pmid":"26090721","id":"PMC_26090721","title":"Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26090721","citation_count":15,"is_preprint":false},{"pmid":"32877504","id":"PMC_32877504","title":"An Integrated Genomic Approach Identifies HOXC8 as an Upstream Regulator in Ovarian Endometrioma.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877504","citation_count":15,"is_preprint":false},{"pmid":"16831908","id":"PMC_16831908","title":"Multiple roles of hoxc8 in skeletal development.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16831908","citation_count":15,"is_preprint":false},{"pmid":"20016939","id":"PMC_20016939","title":"Hoxc8 represses BMP-induced expression of Smad6.","date":"2009","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/20016939","citation_count":14,"is_preprint":false},{"pmid":"19071237","id":"PMC_19071237","title":"Morpholino-mediated knockdown in primary chondrocytes implicates Hoxc8 in regulation of cell cycle progression.","date":"2008","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19071237","citation_count":13,"is_preprint":false},{"pmid":"15674821","id":"PMC_15674821","title":"Dynamic expression pattern of Hoxc8 during mouse early embryogenesis.","date":"2005","source":"The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/15674821","citation_count":12,"is_preprint":false},{"pmid":"20097160","id":"PMC_20097160","title":"Proliferating cell nuclear antigen (Pcna) as a direct downstream target gene of Hoxc8.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20097160","citation_count":12,"is_preprint":false},{"pmid":"17456249","id":"PMC_17456249","title":"Effect of excessive iodine exposure on the placental deiodinase activities and Hoxc8 expression during mouse embryogenesis.","date":"2007","source":"The British journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/17456249","citation_count":12,"is_preprint":false},{"pmid":"12974468","id":"PMC_12974468","title":"Analysis of plausible downstream target genes of Hoxc8 in F9 teratocarcinoma cells. Putative downstream target genes of Hoxc8.","date":"2003","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/12974468","citation_count":12,"is_preprint":false},{"pmid":"36421849","id":"PMC_36421849","title":"Association of HOXC8 Genetic Polymorphisms with Multi-Vertebral Number and Carcass Weight in Dezhou Donkey.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36421849","citation_count":11,"is_preprint":false},{"pmid":"16586448","id":"PMC_16586448","title":"Expression of folate pathway genes in the cartilage of Hoxd4 and Hoxc8 transgenic mice.","date":"2006","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/16586448","citation_count":11,"is_preprint":false},{"pmid":"19214787","id":"PMC_19214787","title":"In vitro osteoblast differentiation is negatively regulated by Hoxc8.","date":"2009","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19214787","citation_count":10,"is_preprint":false},{"pmid":"15384168","id":"PMC_15384168","title":"Comparative cis-regulatory analyses identify new elements of the mouse Hoxc8 early enhancer.","date":"2004","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15384168","citation_count":10,"is_preprint":false},{"pmid":"37099809","id":"PMC_37099809","title":"HOXC8/TGF-β1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37099809","citation_count":9,"is_preprint":false},{"pmid":"22426122","id":"PMC_22426122","title":"Cdx1 is essential for the initiation of HoxC8 expression during early embryogenesis.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22426122","citation_count":9,"is_preprint":false},{"pmid":"15470754","id":"PMC_15470754","title":"Hoxc8 early enhancer of the Indonesian coelacanth, Latimeria menadoensis.","date":"2004","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15470754","citation_count":9,"is_preprint":false},{"pmid":"40615904","id":"PMC_40615904","title":"CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8/NF-κB signaling pathway.","date":"2025","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/40615904","citation_count":8,"is_preprint":false},{"pmid":"17171696","id":"PMC_17171696","title":"Comparison of diverged Hoxc8 early enhancer activities reveals modification of regulatory interactions at conserved cis-acting elements.","date":"2007","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/17171696","citation_count":8,"is_preprint":false},{"pmid":"37885723","id":"PMC_37885723","title":"Comprehensive analysis of HOXC8 associated with tumor microenvironment characteristics in colorectal cancer.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37885723","citation_count":7,"is_preprint":false},{"pmid":"27025388","id":"PMC_27025388","title":"Genes Frequently Coexpressed with Hoxc8 Provide Insight into the Discovery of Target Genes.","date":"2016","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/27025388","citation_count":7,"is_preprint":false},{"pmid":"18835255","id":"PMC_18835255","title":"The third helix of the murine Hoxc8 homeodomain facilitates protein transduction in mammalian cells.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18835255","citation_count":7,"is_preprint":false},{"pmid":"35509266","id":"PMC_35509266","title":"Histone demethylase KDM5A regulates the functions of human periodontal ligament stem cells during periodontitis via the miR-495-3p/HOXC8 axis.","date":"2022","source":"Regenerative therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35509266","citation_count":7,"is_preprint":false},{"pmid":"17094106","id":"PMC_17094106","title":"Mouse naked cuticle 2 (mNkd2) as a direct transcriptional target of Hoxc8 in vivo.","date":"2007","source":"Journal of experimental zoology. Part A, Ecological genetics and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17094106","citation_count":7,"is_preprint":false},{"pmid":"18991027","id":"PMC_18991027","title":"The third helix of the Hoxc8 homeodomain peptide enhances the efficiency of gene transfer in combination with lipofectamine.","date":"2008","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18991027","citation_count":7,"is_preprint":false},{"pmid":"12617829","id":"PMC_12617829","title":"Hoxc-8 expression shows left-right asymmetry in the posterior lateral plate mesoderm.","date":"2002","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12617829","citation_count":7,"is_preprint":false},{"pmid":"28695962","id":"PMC_28695962","title":"Gdf11/Smad signalling and Cdx proteins cooperate to activate the Hoxc8 early enhancer in HepG2 cells.","date":"2017","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28695962","citation_count":6,"is_preprint":false},{"pmid":"38531796","id":"PMC_38531796","title":"DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast Cancer Function and its Contribution to Herceptin Resistance.","date":"2024","source":"Discovery medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38531796","citation_count":5,"is_preprint":false},{"pmid":"37670969","id":"PMC_37670969","title":"HOXC8 mediates osteopontin expression in gastric cancer cells.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37670969","citation_count":5,"is_preprint":false},{"pmid":"1686012","id":"PMC_1686012","title":"Molecular cloning, chromosomal assignment, and nucleotide sequence of the feline homeobox HOX3A.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1686012","citation_count":5,"is_preprint":false},{"pmid":"19621436","id":"PMC_19621436","title":"Generation of conditional Hoxc8 loss-of-function and Hoxc8-->Hoxc9 replacement alleles in mice.","date":"2009","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/19621436","citation_count":5,"is_preprint":false},{"pmid":"27651160","id":"PMC_27651160","title":"The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27651160","citation_count":5,"is_preprint":false},{"pmid":"31638463","id":"PMC_31638463","title":"miR-152 inhibits the proliferation and invasion of chordoma cells by targeting HOXC8.","date":"2019","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/31638463","citation_count":5,"is_preprint":false},{"pmid":"15842175","id":"PMC_15842175","title":"Homology modeling based solution structure of Hoxc8-DNA complex: role of context bases outside TAAT stretch.","date":"2005","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/15842175","citation_count":5,"is_preprint":false},{"pmid":"34856652","id":"PMC_34856652","title":"miR-301a inhibits adipogenic differentiation of adipose-derived stromal vascular fractions by targeting HOXC8 in sheep.","date":"2021","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/34856652","citation_count":5,"is_preprint":false},{"pmid":"12836698","id":"PMC_12836698","title":"Phylogenetic analysis of the mammalian Hoxc8 non-coding region.","date":"2003","source":"Journal of structural and functional genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12836698","citation_count":5,"is_preprint":false},{"pmid":"40701951","id":"PMC_40701951","title":"HOXC8 impacts lung tumorigenesis by preventing pyroptotic cell death through the suppression of caspase-1 expression.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40701951","citation_count":4,"is_preprint":false},{"pmid":"41476080","id":"PMC_41476080","title":"Methionine restriction alleviates kidney fibrosis through epigenetic repression of the TGF-β-Smad3-Hoxc8/P-TEFb axis.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41476080","citation_count":4,"is_preprint":false},{"pmid":"29774580","id":"PMC_29774580","title":"Evaluation of HOXC8 in crested Swiss chicken.","date":"2018","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29774580","citation_count":4,"is_preprint":false},{"pmid":"16949104","id":"PMC_16949104","title":"Efficient cellular uptake of recombinant murine Hoxc8 homeoprotein in COS-7 cells.","date":"2006","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16949104","citation_count":4,"is_preprint":false},{"pmid":"32922885","id":"PMC_32922885","title":"HOXC8: a predictive glioma biomarker that induces epithelia-mesenchymal transition.","date":"2018","source":"Chinese neurosurgical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32922885","citation_count":3,"is_preprint":false},{"pmid":"36308681","id":"PMC_36308681","title":"HOXC8 alleviates high glucose-triggered damage of trophoblast cells during gestational diabetes mellitus via activating TGFβ1-mediated Notch1 pathway.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/36308681","citation_count":3,"is_preprint":false},{"pmid":"37039065","id":"PMC_37039065","title":"Chicken HOXC8 and HOXC10 genes may play a role in the altered skull morphology associated with the Crest phenotype.","date":"2023","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/37039065","citation_count":3,"is_preprint":false},{"pmid":"37627406","id":"PMC_37627406","title":"Effects of HOXC8 on the Proliferation and Differentiation of Porcine Preadipocytes.","date":"2023","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/37627406","citation_count":2,"is_preprint":false},{"pmid":"38348790","id":"PMC_38348790","title":"Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.","date":"2024","source":"Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology","url":"https://pubmed.ncbi.nlm.nih.gov/38348790","citation_count":2,"is_preprint":false},{"pmid":"39395273","id":"PMC_39395273","title":"lncRNA WAC-AS1 promotes the progression of gastric cancer through miR-204-5p/HOXC8 axis.","date":"2024","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39395273","citation_count":2,"is_preprint":false},{"pmid":"39262244","id":"PMC_39262244","title":"Effect of whole-process high-quality nursing on the quality of life of acute pancreatitis patients and the mechanism of miR-126-5p/HOXC8 axis promoting the progression of acute pancreatitis.","date":"2024","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/39262244","citation_count":2,"is_preprint":false},{"pmid":"12480513","id":"PMC_12480513","title":"Xenopus hoxc8 during early development.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12480513","citation_count":2,"is_preprint":false},{"pmid":"41265630","id":"PMC_41265630","title":"HOXC8-activated TRIM22/NF-κB pathway promotes stemness in colorectal cancer.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41265630","citation_count":1,"is_preprint":false},{"pmid":"38390956","id":"PMC_38390956","title":"Identification of a Chondrocyte-Specific Enhancer in the Hoxc8 Gene.","date":"2024","source":"Journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/38390956","citation_count":1,"is_preprint":false},{"pmid":"35542655","id":"PMC_35542655","title":"Retracted Article: Long noncoding RNA DLEU1 promotes cell proliferation and migration of Wilms tumor through the miR-300/HOXC8 axis.","date":"2019","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35542655","citation_count":1,"is_preprint":false},{"pmid":"18446053","id":"PMC_18446053","title":"Membrane transducing activity of recombinant Hoxc8 protein and its possible application as a gene delivery vector.","date":"2008","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18446053","citation_count":1,"is_preprint":false},{"pmid":"41505981","id":"PMC_41505981","title":"HOXC8 derived from cancer-associated fibroblasts regulates lung cancer cell malignant metastasis and ferroptosis by mediating the transcription of GCH1.","date":"2025","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/41505981","citation_count":0,"is_preprint":false},{"pmid":"41760717","id":"PMC_41760717","title":"Establishment of a xenograft model of endometriosis-associated fibrosis using human immortalized endometrial stromal cells overexpressing HOXC8.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41760717","citation_count":0,"is_preprint":false},{"pmid":"35427068","id":"PMC_35427068","title":"Retraction: Long noncoding RNA DLEU1 promotes cell proliferation and migration of Wilms tumor through the miR-300/HOXC8 axis.","date":"2021","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35427068","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47131,"output_tokens":9975,"usd":0.145509,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20380,"output_tokens":5176,"usd":0.11565,"stage2_stop_reason":"end_turn"},"total_usd":0.261159,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Menin associates with a trithorax-family histone methyltransferase complex containing MLL2 and Ash2L that methylates histone H3 on lysine 4; menin is bound to the Hoxc8 locus by chromatin immunoprecipitation, and Men1 knockout cells show decreased Hoxc8 expression.\",\n      \"method\": \"Co-immunoprecipitation, histone methyltransferase activity assay, chromatin immunoprecipitation (ChIP), Men1 knockout mouse/cell analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, in vitro HMT assay, ChIP at the Hoxc8 locus, and genetic KO with defined molecular phenotype in one study\",\n      \"pmids\": [\"14992727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Smad1 physically interacts with Hoxc8 through two regions within its amino-terminal 87 amino acids; one of these regions binds the Hoxc8 homeodomain. Overexpression of these Smad1 interaction domains activates osteopontin transcription and induces osteoblast differentiation and mineralized bone matrix formation in 2T3 cells.\",\n      \"method\": \"Yeast two-hybrid, gel-shift (EMSA), deletion analysis, transient and stable transfection assays, alkaline phosphatase/mineralization readouts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding mapped by deletion mutagenesis, yeast two-hybrid confirmed by EMSA, functional rescue by domain overexpression with differentiation readout\",\n      \"pmids\": [\"10625647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Hoxc8 protein binds DNA sequences in native chromatin and regulates expression of target genes including the mouse homologue of the Drosophila tumour-suppressor gene l(2)gl, identified by immunopurification of chromatin-bound DNA.\",\n      \"method\": \"Immunopurification of DNA bound to Hoxc8 in native chromatin (chromatin-IP precursor approach)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromatin-binding experiment in vivo, single lab, single method\",\n      \"pmids\": [\"8103190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Overexpression of a Hoxc8 transgene in mice causes cartilage defects characterized by accumulation of proliferating chondrocytes and reduced maturation, demonstrating that Hoxc8 controls the progression of cells along the chondrocyte differentiation pathway in a dosage-dependent and Hox-class-specific manner.\",\n      \"method\": \"Transgenic mouse overexpression with skeletal histological and cartilage-maturation phenotypic analysis; comparison with Hoxd4 and Isl-1 transgenics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic loss/gain-of-function with defined cellular phenotype, replicated across dosage levels, specificity demonstrated by comparison with other transgenes\",\n      \"pmids\": [\"9707582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hoxc8 directly binds the osteopontin (OPN/Spp1) promoter in vivo (confirmed by ChIP), repressing its expression ~4.8-fold; Hoxc8 also directly binds regulatory regions of five other genes (including Fzd2) involved in oncogenesis, cell adhesion, proliferation, and apoptosis.\",\n      \"method\": \"Mouse oligonucleotide microarray (16,463 genes), chromatin immunoprecipitation (ChIP) of endogenous Hoxc8 at target gene promoters\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP confirming direct promoter binding combined with expression profiling, multiple target genes validated\",\n      \"pmids\": [\"15699330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A 135 bp early neural tube (ENT) enhancer located ~3 kb upstream of Hoxc8 directs posterior neural tube expression via four interdependent combinatorial elements (A–D); element A is essential but requires interaction with at least two of B, C, or D for activity.\",\n      \"method\": \"Deletion analysis and nucleotide substitution mutagenesis in transgenic mouse reporter assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis of cis-regulatory elements in transgenic mice with defined reporter readout, multiple combinatorial mutations tested\",\n      \"pmids\": [\"8575334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"A fifth cis-acting element (E) in the Hoxc8 early enhancer directs mesoderm expression in combination with elements A–D; different element combinations determine tissue-specific expression (neural tube: ABC/ABD/ACD; somite: ACDE; lateral plate mesoderm: DE), and mutations cause posteriorization of reporter expression.\",\n      \"method\": \"Transgenic mouse reporter assay with systematic cis-element mutation combinations\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic combinatorial mutagenesis in transgenic mice, multiple tissue-specific readouts, replicated across element combinations\",\n      \"pmids\": [\"8901587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Regulatory elements that maintain the anterior boundaries of Hoxc8 expression in neural tube and paraxial mesoderm at later developmental stages are located 11–19 kb downstream of the Hoxc8 gene, demonstrating that long-range cis-regulatory elements govern the late phase of Hoxc8 expression.\",\n      \"method\": \"Yeast homologous recombination (pClasper vector) to clone 27 kb genomic region; reporter transgene analysis in transgenic mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic reporter assay with large genomic fragment, single lab, single approach\",\n      \"pmids\": [\"8637890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Differences in cis-regulatory sequences of the Hoxc8 early enhancer between chicken and mouse cause a temporal delay in Hoxc8 activation in chicken, restricting its paraxial mesoderm expression to a more posterior domain; transgenic mouse assays show the chicken enhancer directs more posterior reporter expression than the mouse enhancer.\",\n      \"method\": \"Comparative sequence analysis; transgenic mouse reporter assays with chicken and mouse Hoxc8 early enhancer constructs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic reporter comparison across species enhancers, single lab\",\n      \"pmids\": [\"9482889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Chromatin immunoprecipitation combined with microarray and high-throughput ChIP identified five direct Hoxc8 target genes (including OPN and Fzd2) out of 34 responsive genes; all five contain Hoxc8 consensus binding sites and encode proteins involved in oncogenesis, cell adhesion, proliferation, and apoptosis.\",\n      \"method\": \"Microarray expression profiling, genome-wide Hoxc8 DNA-binding site analysis, high-throughput ChIP\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (microarray + ChIP) identifying direct binding targets in vivo, single lab\",\n      \"pmids\": [\"16793922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Transcription factor Ap2delta associates with Ash2l and the MLL family histone methyltransferase ALR/MLL2 in a complex that trimethylates H3K4; Ap2delta is required for recruitment of this complex to the Hoxc8 locus, leading to H3K4me3 and Hoxc8 transcriptional activation.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, ChIP for Ash2l/Alr and H3K4me3 at Hoxc8 locus, dose-dependent transactivation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid confirmed by endogenous Co-IP, ChIP at specific locus, functional transactivation assay, multiple orthogonal methods\",\n      \"pmids\": [\"18495928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lsh controls CpG methylation at the Hoxc8 locus; in wild-type cells, DNA methylation at Hoxc8 is associated with RNA Pol II stalling (not failure to bind) as the silencing mechanism. In Lsh-/- cells, hypomethylation at Hoxc8 permits efficient Pol II transcriptional elongation facilitated by the chromodomain protein Chd1.\",\n      \"method\": \"Lsh knockout mouse cells, DNA methylation analysis, Pol II ChIP, nucleosomal mapping, Chd1 functional assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple molecular readouts (methylation, Pol II ChIP, splicing), dynamic methylation manipulation experiments\",\n      \"pmids\": [\"20161795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HOXC8 inhibits androgen receptor (AR)-mediated transcriptional induction in prostate cancer cells by blocking hormone-dependent recruitment of the coactivator SRC-3 and CBP to androgen-regulated gene enhancers, inhibiting histone acetylation; forced SRC-3 expression reverses HOXC8-mediated inhibition, and co-immunoprecipitation shows HOXC8 disrupts the AR–SRC-3 interaction.\",\n      \"method\": \"Transient transfection, ChIP for SRC-3/CBP/histone acetylation at PSA enhancer, co-immunoprecipitation, SRC-3 rescue experiment\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP at specific androgen-regulated loci, Co-IP for AR–SRC-3 interaction, genetic rescue by SRC-3 overexpression, multiple orthogonal methods\",\n      \"pmids\": [\"21047772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Immunoprecipitation of Pbx1 in prostate cancer DU145 cells reveals a Pbx1–HoxC8 heterocomplex; siRNA knockdown of either Pbx1 or HoxC8 suppresses androgen-independent cell growth, and double knockdown suppresses growth more significantly, indicating functional cooperation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, cell proliferation assay, DNA microarray\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP for complex, siRNA knockdown with proliferation readout, two orthogonal methods, single lab\",\n      \"pmids\": [\"16637071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HOXC8 is required for cadherin 11 (CDH11) expression in breast cancer cells; HOXC8 depletion reduces CDH11 levels, actin-based membrane ruffles, and Rac activity; CDH11 interacts physically with Trio (a Rac GEF) and is required for Trio plasma membrane localization and Rac activation, placing HOXC8 upstream of a CDH11–Trio–Rac signaling axis in cell migration.\",\n      \"method\": \"siRNA knockdown, ectopic expression, co-immunoprecipitation (CDH11–Trio), Rac activity assay, active-Rac1 rescue, confocal imaging of membrane ruffles and Trio localization\",\n      \"journal\": \"Genes & cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis established by rescue experiments, Co-IP for CDH11–Trio interaction, Rac activity assay, multiple orthogonal methods\",\n      \"pmids\": [\"22593800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HOXC8 directly binds the CDH11 promoter at nucleotides -196 to -191 and acts as a transcriptional activator; depletion of HOXC8 reduces anchorage-independent growth, migration/invasion, and metastasis, all of which are rescued by ectopic CDH11 expression.\",\n      \"method\": \"Chromatin immunoprecipitation, luciferase promoter assay, siRNA knockdown, ectopic CDH11 rescue, soft-agar and invasion assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP confirming direct promoter binding, site-specific luciferase assay, genetic rescue establishing epistasis, multiple functional readouts\",\n      \"pmids\": [\"24810778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HOXC8 directly binds the embigin (EMB) promoter at nucleotides -2303 to -2315 and acts as a transcriptional repressor; HOXC8 knockdown increases EMB expression, and the pro-tumorigenic effects of HOXC8 knockdown (increased proliferation, migration) are rescued by co-depletion of embigin.\",\n      \"method\": \"Western blot, luciferase reporter gene assay, chromatin immunoprecipitation, siRNA knockdown, epistasis rescue experiments\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP at specific promoter site, luciferase assay, genetic rescue establishing epistasis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26090721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Endogenous Hoxc8 binds directly to the enhancer region of mouse naked cuticle 2 (mNkd2) gene; introduction of exogenous Hoxc8 into NIH3T3 cells reduces mNkd2 mRNA expression, establishing mNkd2 as a direct transcriptional target through which Hoxc8 cross-talks with the Wnt signaling pathway.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), reporter assay, mRNA expression analysis after Hoxc8 overexpression\",\n      \"journal\": \"Journal of experimental zoology. Part A, Ecological genetics and physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — three orthogonal methods (ChIP, EMSA, reporter assay) in single lab establishing direct binding and transcriptional repression\",\n      \"pmids\": [\"17094106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hoxc8 overexpression suppresses basal Smad6 promoter activity and BMP2/Smad1-induced Smad6 transcription; ChIP from mouse embryos shows both Smad1 and Hoxc8 are present at the Smad6 promoter, suggesting Hoxc8 regulates Smad6 indirectly through a complex with Smad1 (no direct Hox binding motif in the Smad6 promoter).\",\n      \"method\": \"Promoter luciferase assay, RT-PCR, chromatin immunoprecipitation with anti-Smad1 and anti-Hoxc8 antibodies in mouse embryos\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP in embryos + promoter assay, but indirect mechanism proposed since no Hox binding motif in promoter; single lab\",\n      \"pmids\": [\"20016939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Proliferating cell nuclear antigen (Pcna) is a direct transcriptional target of Hoxc8; Hoxc8 binds Hox core and Hox-Pbx binding sequences in the Pcna upstream regulatory region (confirmed by ChIP in embryos), overexpression of Hoxc8 increases Pcna transcript levels and cell proliferation rate.\",\n      \"method\": \"Chromatin immunoprecipitation in mouse embryos (E11.5), promoter sequence analysis, Hoxc8 overexpression with RT-PCR and proliferation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP in vivo confirming direct binding, functional overexpression assay; single lab, two methods\",\n      \"pmids\": [\"20097160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Retinaldehyde dehydrogenase 2 (Raldh2) conditional knockout causes loss of Lim1+ brachial motoneurons and Islet1+ neuron mispositioning; the molecular basis involves deregulation of Hoxc8, which regulates RARbeta. Hoxc8 mutant mice exhibit the same motoneuron specification defects (phenocopy), establishing Hoxc8 downstream of Raldh2/RA signaling in brachial motoneuron specification.\",\n      \"method\": \"Conditional knockout (Raldh2 and Hoxc8 null mice), immunofluorescence for motoneuron markers (Lim1, Islet1), molecular phenotype comparison\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis by two independent mouse KO models with defined molecular and cellular phenotypes\",\n      \"pmids\": [\"15753214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LMP1 (EBV) represses HoxC8 expression in nasopharyngeal carcinoma cells via RNA Pol II stalling, partially reversible by irradiation through epigenetic regulator TET3; HoxC8 modulates glycolysis and regulates TCA cycle-related gene expression, and ectopic HoxC8 inhibits NPC cell growth in vitro and in vivo.\",\n      \"method\": \"RNA Pol II ChIP, TET3 manipulation, ectopic HoxC8 expression, glycolysis assays, in vivo xenograft\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Pol II ChIP mechanistic data, functional ectopic expression with metabolic and in vivo readouts; single lab\",\n      \"pmids\": [\"25745994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HOXC8 functions as a transcriptional activator of TGFβ1, and this elevated TGFβ1 mediates HOXC8-driven proliferation, anchorage-independent growth, migration, and chemoresistance in non-small cell lung cancer cells.\",\n      \"method\": \"ChIP, promoter luciferase assay, siRNA knockdown, ectopic overexpression, TGFβ1 blocking rescue experiments, colony formation and migration assays\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase assay for direct TGFβ1 transcriptional activation, functional rescue experiments; single lab\",\n      \"pmids\": [\"29367650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ILF3 physically interacts with HOXC8 (co-immunoprecipitation and mass spectrometry) and they cooperate to activate CDH11 transcription; ILF3 binds CDH11 promoter at specific nucleotide positions and requires HOXC8 for co-activation.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, ChIP, luciferase reporter assay, siRNA knockdown\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP + MS for interaction, ChIP for binding, luciferase for co-activation; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29296180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HOXC8 directly activates transcription of MGP (matrix Gla protein) by binding its promoter; elevated MGP promotes EMT and drives proliferation and migration specifically in triple-negative breast cancer cells.\",\n      \"method\": \"Chromatin immunoprecipitation, luciferase assay, siRNA knockdown and overexpression, EMT marker analysis\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus luciferase confirming direct binding and transcriptional activation, functional knockdown/OE; single lab\",\n      \"pmids\": [\"31264274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Sustained Hoxc8 activity is required not only to establish but also to maintain terminal differentiation markers in brachial spinal motor neurons postnatally; conditional inactivation of Hoxc8 at successive developmental stages causes motor deficits, and in vitro-generated MNs show Hoxc8 is sufficient to induce terminal differentiation gene expression directly.\",\n      \"method\": \"Conditional Hoxc8 knockout in mice at successive stages, transcriptomics of brachial MNs, motor behavioral assays, in vitro MN generation with Hoxc8 gain/loss-of-function\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO at multiple stages with defined behavioral and molecular phenotypes, in vitro gain-of-function, transcriptomic validation\",\n      \"pmids\": [\"35315772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cdx1 directly binds three pairs of conserved Cdx binding sites in the HoxC8 early enhancer during Xenopus embryogenesis (confirmed by ChIP); Cdx1 overexpression or knockdown causes precocious or delayed HoxC8 expression respectively, establishing Cdx1 as a direct transcriptional activator of HoxC8 expression.\",\n      \"method\": \"Xenopus Cdx1 overexpression and antisense morpholino knockdown, transgenic reporter (mouse HoxC8 early enhancer in Xenopus), ChIP for Cdx1 binding in embryos, Cdx binding site mutagenesis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP in embryos confirming direct binding, gain- and loss-of-function genetic experiments, mutagenesis of binding sites; multiple orthogonal methods\",\n      \"pmids\": [\"22426122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gdf11/Smad signaling and Cdx proteins synergistically activate the Hoxc8 early enhancer; mutagenesis identified two Smad binding motifs and two Cdx binding motifs as required elements; Gdf11 stimulation is partially inhibited by Specific Inhibitor of Smad3, implicating Smad3 in signal transduction.\",\n      \"method\": \"Luciferase reporter transfection in HepG2 cells, Gdf11/Cdx overexpression, site-directed mutagenesis of enhancer motifs, Smad3 inhibitor\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of specific binding sites in reporter assay, pharmacological inhibition; single lab, cell-line model\",\n      \"pmids\": [\"28695962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The 16 amino acid third helix (residues 191–206) of the Hoxc8 homeodomain is a protein transduction domain (PTD) sufficient for cellular membrane penetration; transduction efficiency increases with PTD copy number. The homeodomain region of Hoxc8 is also required for forming protein–DNA complexes that can be delivered intracellularly.\",\n      \"method\": \"GFP-fusion protein transduction assay in primary pig fibroblasts and COS-7 cells, gel retardation/agarose gel DNA-complex assay, concentration-response and multimer experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct transduction assay with peptide domain, replicated in multiple cell types, dose-response characterized; single lab\",\n      \"pmids\": [\"18835255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOXC8 activates TGFβ1 transcription and enhances phosphorylated Smad2/Smad3 levels in hepatic stellate cells, creating a positive feedback loop; knockdown of HOXC8 suppresses TGF-β1-induced HSC activation and fibrotic gene (α-SMA, COL1a1) induction in vitro and alleviates liver fibrosis in a CCl4 mouse model in vivo.\",\n      \"method\": \"HOXC8 overexpression and knockdown in LX-2 cells and CCl4 mouse model, Western blot for phospho-Smad2/3, qPCR for fibrotic genes, luciferase/ChIP implied by context of TGFβ1 activation claim\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO phenotype plus in vitro mechanistic signaling data; positive feedback loop inferred from expression data; single lab\",\n      \"pmids\": [\"37099809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HOXC8 negatively regulates CASP1 (caspase-1) expression by recruiting HDAC1/2 to the CASP1 promoter; HOXC8 and HDAC1 are in the same immunocomplex and HOXC8 is required for HDAC1 recruitment to the CASP1 promoter, suppressing CASP1 transcription and thereby preventing pyroptosis in NSCLC cells.\",\n      \"method\": \"Co-immunoprecipitation (HOXC8–HDAC1), ChIP (HOXC8 and HDAC1 at CASP1 promoter), siRNA knockdown, YVAD/disulfiram rescue of pyroptosis, CASP1 forced expression, cholesterol-conjugated siRNA in vivo\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP for complex, ChIP for direct promoter binding and HDAC1 recruitment, pharmacological and genetic rescue establishing mechanism, in vivo validation; multiple orthogonal methods\",\n      \"pmids\": [\"40701951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Hoxc8 is a central pro-fibrotic transcription factor downstream of TGF-β–Smad3 signaling in kidney fibrosis; Hoxc8 reinforces its own expression and drives fibrotic gene programs by recruiting the P-TEFb transcriptional elongation complex; fibroblast-specific Hoxc8 deletion protects mice from renal fibrosis.\",\n      \"method\": \"Transcriptomic and cistromic (ChIP-seq implied) analyses, fibroblast-specific conditional Hoxc8 knockout mice, methionine restriction dietary model, histone mark analysis at Hoxc8 locus\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined fibrosis phenotype, cistromic identification of P-TEFb recruitment, epigenomic analysis; multiple orthogonal approaches in single study\",\n      \"pmids\": [\"41476080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"miR-196a/b directly targets the HOXC8 3'UTR (confirmed by luciferase reporter), suppressing HOXC8 protein expression; HOXC8 knockdown suppresses breast cancer cell migration and metastasis, and ectopic HOXC8 expression rescues the anti-migratory effect of miR-196, placing HOXC8 downstream of miR-196 in a migration-regulatory axis.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, siRNA knockdown, lentiviral miRNA overexpression, in vitro invasion, in vivo spontaneous metastasis assay, HOXC8 ectopic rescue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct 3'UTR validation, genetic epistasis by rescue, both in vitro and in vivo functional readouts\",\n      \"pmids\": [\"20736365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"miR-196a directly interacts with the HOX-C8 3'UTR (confirmed by luciferase assay with different HOX-C8 3'UTR fragments), and stable miR-196a expression down-regulates HOX-C8 in melanoma cells, leading to changes in HOX-C8 target genes cadherin-11, calponin-1, and osteopontin.\",\n      \"method\": \"Luciferase 3'UTR reporter assay with deletion fragments, stable miR-196a transfection, target gene expression analysis\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3'UTR luciferase validation, gene expression downstream effects; single lab\",\n      \"pmids\": [\"21077158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLX5 and HOXC8 form a protein complex and together bind and negatively regulate the LINC01013 lncRNA promoter; co-expression of DLX5 and HOXC8 enhances chondrogenic differentiation of stem cells from apical papilla (SCAPs) in vitro and restores cartilage defect in a rabbit knee model in vivo.\",\n      \"method\": \"Co-immunoprecipitation (DLX5–HOXC8 complex), ChIP at LINC01013 promoter, Western blot, Alcian Blue staining, pellet culture, in vivo rabbit cartilage transplantation\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for complex, ChIP at promoter, in vivo functional assay; single lab with multiple methods\",\n      \"pmids\": [\"32631410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HOXC8 in cancer-associated fibroblasts (CAFs) directly binds the GCH1 promoter and activates its transcription (confirmed by dual luciferase reporter and bioinformatics); HOXC8-driven GCH1 upregulation suppresses ferroptosis and promotes lung cancer cell malignant progression; si-HOXC8 in CAFs inhibited tumor growth and GCH1 expression in vivo.\",\n      \"method\": \"Dual luciferase reporter assay, bioinformatics binding analysis, siRNA knockdown, GCH1 overexpression rescue, xenograft tumor model, IHC\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay confirming direct promoter binding, genetic rescue establishing epistasis, in vivo validation; single lab\",\n      \"pmids\": [\"41505981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HOXC8 transcriptionally activates TRIM22 expression, leading to ubiquitination and degradation of IκBα and subsequent NF-κB signaling activation; this HOXC8/TRIM22/NF-κB axis drives stemness and chemoresistance in colorectal cancer cells.\",\n      \"method\": \"ChIP for HOXC8 at TRIM22 promoter, IκBα ubiquitination assay, NF-κB pathway reporter, siRNA knockdown and overexpression, stemness/sphere-formation assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct TRIM22 promoter binding, ubiquitination assay, pathway rescue; single lab\",\n      \"pmids\": [\"41265630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HOXC8 overexpression in endometrial stromal cells significantly enhances cell proliferation, migration, adhesion, and fibrotic activities, and increases phosphorylated SMAD2/SMAD3 levels; the adhesion and fibrosis activities induced by HOXC8 are blocked by TGF-β receptor type I kinase inhibitor E-616452, placing HOXC8 upstream of TGF-β/SMAD signaling.\",\n      \"method\": \"HOXC8 overexpression in euESCs, cell function assays (proliferation, migration, adhesion, fibrosis), Western blot for phospho-SMAD2/3, pharmacological TGFβRI inhibition\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with multiple functional readouts and pharmacological pathway inhibition; single lab\",\n      \"pmids\": [\"32877504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Morpholino-mediated knockdown of Hoxc8 in primary chondrocytes reduces cell proliferation (decreased PCNA expression and phospho-histone H3) without apoptosis, and causes cells to be delayed in M-phase progression, implicating Hoxc8 in cell cycle control at the M-phase checkpoint.\",\n      \"method\": \"Morpholino antisense knockdown in primary chondrocytes, PCNA immunostaining, phospho-Histone H3 staining, BrdU incorporation, flow cytometry\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct knockdown in primary cells with cell-cycle marker readouts; single lab, single method\",\n      \"pmids\": [\"19071237\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HOXC8 is a homeodomain transcription factor that directly binds DNA at target gene promoters/enhancers to activate or repress transcription; it interacts physically with Smad1/BMP-pathway components, the Pbx1 co-factor, SRC-3 coactivator, ILF3, DLX5, HDAC1, and P-TEFb; its locus is epigenetically regulated by menin/MLL2-Ash2L H3K4 methyltransferase complex (recruited by Ap2delta), by Lsh-dependent DNA methylation causing Pol II stalling, and by KDM5A-mediated H3K4 demethylation; upstream, it is activated by Cdx1 binding to its early enhancer and by TGF-β/Smad3 signaling, and post-transcriptionally repressed by miR-196 family members targeting its 3'UTR; functionally, HOXC8 controls chondrocyte proliferation and differentiation, brachial motoneuron specification and terminal differentiation, osteoblast differentiation (as a negative regulator), and in cancer contexts drives migration/invasion via a CDH11–Trio–Rac axis, suppresses pyroptosis by recruiting HDAC1/2 to repress CASP1 transcription, and promotes fibrosis through TGFβ1 positive feedback and P-TEFb recruitment.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HOXC8 is a homeodomain transcription factor that directs anteroposterior patterning of the developing skeleton and nervous system and is repeatedly redeployed as a driver of cancer and fibrosis [#2, #3, #20]. It binds DNA at Hox core and Hox-Pbx consensus sites in native chromatin to either activate or repress target promoters, regulating genes governing cell adhesion, proliferation, oncogenesis, and apoptosis [#2, #4, #9, #19]. In development, HOXC8 controls progression of chondrocytes through differentiation in a dosage-dependent manner [#3, #38] and acts downstream of retinaldehyde/RA signaling to specify and maintain terminal differentiation of brachial spinal motor neurons, with sustained activity required postnatally [#20, #25]. Its developmental expression is established and bounded by a modular early enhancer whose combinatorial cis-elements direct distinct neural tube, somite, and lateral plate mesoderm domains [#5, #6, #7]; this enhancer integrates Cdx1 and Gdf11/Smad3 inputs that time and position HOXC8 activation [#26, #27]. HOXC8 partners directly with Smad1 through its homeodomain to control BMP-responsive osteogenic transcription [#1], and forms complexes with Pbx1, ILF3, DLX5, and HDAC1/2 to specify target selection and activity [#13, #23, #34, #30]. In cancer, HOXC8 activates CDH11 to engage a CDH11–Trio–Rac migration axis and drive invasion and metastasis [#14, #15], suppresses pyroptosis by recruiting HDAC1/2 to repress CASP1 [#30], and acts upstream of TGFβ1/Smad signaling; in hepatic stellate cells and renal fibroblasts it establishes a TGFβ1–Smad positive-feedback loop and recruits the P-TEFb elongation complex to drive fibrotic gene programs [#22, #29, #31, #37]. The HOXC8 locus is itself a node of epigenetic control, activated by Ap2δ-recruited menin/MLL2-Ash2L H3K4 methyltransferase activity and silenced by Lsh-dependent DNA methylation that stalls RNA Pol II [#0, #10, #11]; post-transcriptionally, miR-196 family members target its 3'UTR to limit HOXC8 protein and its migratory output [#32, #33].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that Hoxc8 protein occupies specific DNA sequences in living chromatin and regulates downstream target genes, defining it as a sequence-specific transcriptional regulator rather than merely a patterning marker.\",\n      \"evidence\": \"Immunopurification of Hoxc8-bound DNA from native chromatin in mouse\",\n      \"pmids\": [\"8103190\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding motif not yet defined\", \"Activation versus repression at targets not resolved\", \"Single method, single lab\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved how spatial and temporal HOXC8 expression is encoded, showing combinatorial cis-regulatory elements in an early enhancer plus long-range downstream elements partition expression into tissue-specific domains.\",\n      \"evidence\": \"Systematic cis-element mutagenesis in transgenic mouse reporters and large genomic fragment analysis\",\n      \"pmids\": [\"8575334\", \"8901587\", \"8637890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors binding each element not identified at this stage\", \"Mechanism of element interdependence unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated that HOXC8 dosage controls chondrocyte differentiation progression, linking the patterning factor to a concrete cellular differentiation phenotype.\",\n      \"evidence\": \"Transgenic mouse overexpression with cartilage histology, compared against other Hox transgenes\",\n      \"pmids\": [\"9707582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chondrocyte target genes not identified\", \"Molecular mechanism of maturation arrest unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified a direct physical link between HOXC8 and BMP signaling, showing Smad1 binds the homeodomain to control osteogenic transcription and bone matrix formation.\",\n      \"evidence\": \"Yeast two-hybrid, EMSA, deletion mapping, and differentiation/mineralization assays in 2T3 cells\",\n      \"pmids\": [\"10625647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide Smad1–Hoxc8 co-targets not mapped\", \"Whether interaction is activating or repressive context-dependent\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided genome-scale direct target identification, defining a HOXC8 consensus and a cohort of bound, regulated genes (e.g., OPN, Fzd2) implicated in adhesion, proliferation, and apoptosis.\",\n      \"evidence\": \"Expression microarray combined with high-throughput ChIP for endogenous Hoxc8\",\n      \"pmids\": [\"15699330\", \"16793922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type dependence of target repertoire not addressed\", \"Co-factor requirements at each site not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed HOXC8 cooperates with the Pbx1 co-factor in a heterocomplex to sustain androgen-independent prostate cancer growth, framing HOXC8 as a context-dependent oncogenic regulator.\",\n      \"evidence\": \"Co-IP and siRNA double knockdown with proliferation readouts in DU145 cells\",\n      \"pmids\": [\"16637071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct co-bound target genes not identified\", \"Two methods, single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined epigenetic activation of the Hoxc8 locus by H3K4 methyltransferase complexes, showing Ap2δ recruits Ash2l/MLL2 to deposit H3K4me3 and drive transcription, building on the earlier menin–MLL2 link.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, locus ChIP for Ash2l/Alr and H3K4me3, transactivation assay\",\n      \"pmids\": [\"18495928\", \"14992727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling Ap2δ recruitment unknown\", \"Relationship to repressive marks not integrated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed a silencing mechanism in which Lsh-dependent CpG methylation at the locus stalls RNA Pol II elongation rather than blocking recruitment, identifying elongation control as a key regulatory layer.\",\n      \"evidence\": \"Lsh knockout cells with methylation analysis, Pol II ChIP, nucleosome mapping, and Chd1 assays\",\n      \"pmids\": [\"20161795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger for Lsh-mediated methylation not defined\", \"Interplay with activating H3K4 machinery unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established post-transcriptional control of HOXC8 by miR-196 family targeting of its 3'UTR, placing HOXC8 downstream of a microRNA axis governing cancer cell migration and metastasis.\",\n      \"evidence\": \"3'UTR luciferase reporters, miRNA overexpression, in vitro/in vivo metastasis with HOXC8 rescue\",\n      \"pmids\": [\"20736365\", \"21077158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of individual miR-196 family members unclear\", \"Upstream regulation of miR-196 not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed HOXC8 antagonizes nuclear receptor coactivation, blocking AR-dependent SRC-3/CBP recruitment and histone acetylation, demonstrating it can act by sequestering coactivators.\",\n      \"evidence\": \"ChIP at the PSA enhancer, Co-IP, and SRC-3 overexpression rescue in prostate cancer cells\",\n      \"pmids\": [\"21047772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across other nuclear receptors not tested\", \"Structural basis of AR–SRC-3 disruption unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected HOXC8 to a defined cytoskeletal signaling axis, showing it drives CDH11 expression to enable Trio-dependent Rac activation and membrane ruffling in migrating breast cancer cells.\",\n      \"evidence\": \"siRNA, Co-IP (CDH11–Trio), Rac activity assays, active-Rac1 rescue, and imaging\",\n      \"pmids\": [\"22593800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HOXC8 binds CDH11 directly resolved only later\", \"In vivo relevance of the Trio–Rac axis not tested here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirmed direct, site-specific HOXC8 activation of the CDH11 promoter and established epistasis, with CDH11 re-expression rescuing migration, invasion, and metastasis defects.\",\n      \"evidence\": \"ChIP, site-mapped luciferase assays, siRNA, CDH11 rescue, soft-agar and invasion assays\",\n      \"pmids\": [\"24810778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-factors at the CDH11 promoter defined only in later work\", \"Determinants of activation versus repression at different targets unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified TGFβ1 as a direct HOXC8 transcriptional target mediating proliferation, anchorage independence, migration, and chemoresistance, linking HOXC8 to TGFβ-driven malignancy.\",\n      \"evidence\": \"ChIP, luciferase, knockdown/overexpression, and TGFβ1-blocking rescue in NSCLC cells\",\n      \"pmids\": [\"29367650\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Feedback architecture established only in later fibrosis studies\", \"Single lung cancer context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that HOXC8 is required continuously, not just transiently, to maintain motor neuron terminal differentiation, redefining it as a sustained identity factor rather than an initiation-only switch.\",\n      \"evidence\": \"Stage-specific conditional Hoxc8 knockout, brachial MN transcriptomics, behavior, and in vitro gain-of-function\",\n      \"pmids\": [\"35315772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct terminal differentiation target genes not exhaustively mapped\", \"Maintenance co-factors not identified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mechanistically unified HOXC8 as a pro-fibrotic master regulator that establishes a TGFβ1–Smad self-reinforcing loop and recruits the P-TEFb elongation complex to drive fibrotic transcription in liver and kidney.\",\n      \"evidence\": \"Conditional/fibroblast-specific knockouts, CCl4 and renal fibrosis models, phospho-Smad and cistromic/histone analyses\",\n      \"pmids\": [\"37099809\", \"41476080\", \"32877504\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism of P-TEFb recruitment to the HOXC8 cistrome not structurally defined\", \"How fibrotic and developmental target programs are partitioned unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended HOXC8 repressive output to programmed cell death, showing it recruits HDAC1/2 to silence CASP1 and suppress pyroptosis, demonstrating a chromatin-modifier-based repression mechanism.\",\n      \"evidence\": \"Co-IP (HOXC8–HDAC1), ChIP for HOXC8/HDAC1 at the CASP1 promoter, rescue experiments, and in vivo siRNA in NSCLC\",\n      \"pmids\": [\"40701951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants directing HDAC recruitment to specific promoters unknown\", \"Generality of pyroptosis suppression beyond NSCLC untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved what molecular logic dictates whether HOXC8 activates or represses a given target and how its developmental versus pro-fibrotic/oncogenic cistromes are selected across cell types.\",\n      \"evidence\": \"No single study in the corpus integrates the co-factor/chromatin determinants of HOXC8 target choice across contexts\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model of activator-versus-repressor switching\", \"Cell-type-specific cistrome determinants not defined\", \"Structural basis of partner-directed target selection unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 4, 9, 15, 16, 17, 22, 24, 30, 31]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 4, 15, 16, 17, 28]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [12, 18, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4, 9, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 9, 15, 16, 30, 31]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 5, 6, 20, 25]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 10, 11, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 14, 22, 29, 36]}\n    ],\n    \"complexes\": [\"P-TEFb (recruited)\"],\n    \"partners\": [\"SMAD1\", \"PBX1\", \"ILF3\", \"DLX5\", \"HDAC1\", \"NCOA3\", \"TRIO\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}